Search for: "Eli Lilly & Co."
Results 121 - 140
of 1,010
Sort by Relevance
|
Sort by Date
21 Dec 2018, 9:14 am
This arose in the context of the drug Tadalafil which treats male erectile dysfunction and has a European patent owned by ICOS and exclusively licensed to Eli Lilly. [read post]
7 Dec 2018, 2:23 pm
”AbbVie, 764 F.3d at 1372 (citing Eli Lilly & Co. v. [read post]
7 Dec 2018, 3:00 am
According to the study, they include GE, Intel, Pfizer, Allstate, Medtronic, Eli Lilly, Southwest Airlnes, AEP, Ingersoll Rand, Praxair, Entergy, Clorox, NiSource & Dentsply Sirona. [read post]
1 Nov 2018, 6:26 am
The warning applies to the class of SGLT2 inhibitors, specifically, Johnson & Johnson’s Invokana (canagliflozin), AstraZeneca Plc’s Farxiga (dapagliflozin), and Eli Lilly & Co. [read post]
11 Oct 2018, 12:57 am
Here the court agreed with MSD’s appeal in that the HIPO’s interpretation of the Eli Lilly judgment was wrong: it does not follow from this judgment that the concerned active ingredient should be mentioned by name or by structure in the description. [read post]
29 Sep 2018, 8:09 pm
True Health Diagnostics LLC -- Eli Lilly & Co. v. [read post]
13 Jul 2018, 5:48 pm
Eli Lilly & Co. v. [read post]
5 Jul 2018, 7:20 am
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
5 Jul 2018, 7:20 am
Indianapolis, Indiana – Attorneys for Plaintiff, Eli Lilly and Company of Indianapolis, Indiana filed suit in the Southern District of Indiana alleging that Defendants, Dr. [read post]
21 Jun 2018, 12:50 pm
Eli Lilly & Co. v. [read post]
1 Jun 2018, 12:13 pm
Eli Lilly & Co. v. [read post]
21 May 2018, 7:22 pm
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
18 May 2018, 5:25 am
Eli Lilly& Co., 598 F.3d 1336, 1351 (Fed. [read post]
16 Mar 2018, 12:00 am
In Eli Lilly & Co., 2018 BL 7440 (Jan. 8, 2018), Eli Lilly & Company (“Eli Lilly”) asked the staff of the Securities and Exchange Commission (“SEC”) to permit the omission of a proposal submitted by William Steiner (“Shareholder”) requesting the board to replace the company’s supermajority voting requirement with a simple majority requirement. [read post]
14 Mar 2018, 8:41 am
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
1 Mar 2018, 2:35 pm
For instance, earlier this year Eli Lilly & Co. reached a settlement over federal product liability lawsuits pending for damage caused by its testosterone drug Axiron. [read post]
1 Mar 2018, 2:35 pm
For instance, earlier this year Eli Lilly & Co. reached a settlement over federal product liability lawsuits pending for damage caused by its testosterone drug Axiron. [read post]
23 Feb 2018, 4:15 am
Eli Lilly and Co. v. [read post]
23 Feb 2018, 4:15 am
Eli Lilly and Co. v. [read post]
31 Jan 2018, 10:05 pm
Article 3(a): a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
